ArticleScientific reports2026
GIPSy2: high-performance and scalable genomic island prediction software.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dealing with genomic mobility is a complex task for current predictors. With an increasing number of sequencing genomes, there is a constant demand for software that can handle multiple inputs. Considering this, we present the Genomic Island Prediction Software 2 (GIPSy2), a new version of well-established software for predicting bacterial genomic islands and mobilome. Statistical methods were used to provide the values associated with each prediction, such as Fisher's exact test, Support vector machine, and Logistic regression. The new version also improves scalability, allowing the simultaneous analysis of multiple genomes, and provides structured outputs to facilitate interpretation and reproducibility. Comparative analyses show that GIPSy2 achieves performance comparable to the original version under default settings, while offering increased flexibility through user-defined parameterization. These improvements make GIPSy2 a versatile tool for genomic island prediction across diverse bacterial datasets. GIPSy2 is currently available on Zenodo repository at https://zenodo.org/doi/10.5281/zenodo.10222587 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.